Circadian rhythms of glucocorticoid hormone actions in target tissues: Potential clinical implications

Science Signaling

Volumn 5, Issue 244, 2012, Pages

  Kino, Tomoshige ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HETERODIMER; HYDROCORTISONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN BMAL1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACETYLATION; ADAPTATION; CIRCADIAN RHYTHM; ENVIRONMENTAL CHANGE; GENE EXPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLISM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; STRESS; SUPRACHIASMATIC NUCLEUS;

ACETYLATION; ARNTL TRANSCRIPTION FACTORS; AUDIOVISUAL AIDS; BLOTTING, WESTERN; CELLS, CULTURED; CIRCADIAN RHYTHM; CLOCK PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; HCT116 CELLS; HELA CELLS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEUKOCYTES, MONONUCLEAR; PITUITARY-ADRENAL SYSTEM; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; SUPRACHIASMATIC NUCLEUS;

EID: 84867127614     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003333     Document Type: Review

References (34)

1. G. P. Chrousos, Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5, 374-381 (2009).
2. G. P. Chrousos, T. Kino, Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10, 213-219 (2007).
3. N. Nader, G. P. Chrousos, T. Kino, Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 21, 277-286 (2010).
4. G. P. Chrousos, P. W. Gold, The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267, 1244-1252 (1992).
5. G. P. Chrousos, The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351-1362 (1995).
6. T. Kino, M. U. De Martino, E. Charmandari, M. Mirani, G. P. Chrousos, Tissue glucocorticoid resistance/ hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 85, 457-467 (2003).
7. T. Kino, G. P. Chrousos, in Handbook on Stress and the Brain, T. Steckler, N. H. Kalin, J. M. H. M. Reul, Eds. (Elsevier, Amsterdam, 2005), pp. 295-312.
8. S. M. Hollenberg, C. Weinberger, E. S. Ong, G. Cerelli, A. Oro, R. Lebo, E. B. Thompson, M. G. Rosenfeld, R. M. Evans, Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641 (1985).
9. V. Giguère, S. M. Hollenberg, M. G. Rosenfeld, R. M. Evans, Functional domains of the human glucocorticoid receptor. Cell 46, 645-652 (1986).
10. T. Kino, G. P. Chrousos, Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: Circadian rhythm-associated alterations of glucocorticoid actions in target tissues. Mol. Cell. Endocrinol. 336, 23-30 (2011).
11. N. Cermakian, P. Sassone-Corsi, Multilevel regulation of the circadian clock. Nat. Rev. Mol. Cell Biol. 1, 59-67 (2000).
12. J. S. Takahashi, H. K. Hong, C. H. Ko, E. L. McDearmon, The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat. Rev. Genet. 9, 764-775 (2008).
13. J. H. Meijer, W. J. Schwartz, In search of the pathways for light-induced pacemaker resetting in the suprachiasmatic nucleus. J. Biol. Rhythms 18, 235-249 (2003).
14. C. H. Ko, J. S. Takahashi, Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 15 (Spec. No. 2), R271-R277 (2006).
15. A. Kalsbeek, I. F. Palm, S. E. La Fleur, F. A. Scheer, S. Perreau-Lenz, M. Ruiter, F. Kreier, C. Cailotto, R. M. Buijs, SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms 21, 458-469 (2006).
16. T. Yoshikawa, M. Sellix, P. Pezuk, M. Menaker, Timing of the ovarian circadian clock is regulated by gonadotropins. Endocrinology 150, 4338-4347 (2009).
17. B. Staels, When the Clock stops ticking, metabolic syndrome explodes. Nat. Med. 12, 54-55, discussion 55 (2006).
18. A. M. Bao, G. Meynen, D. F. Swaab, The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res. Rev. 57, 531-553 (2008).
19. T. Kino, E. Charmandari, G. P. Chrousos, Glucocorticoid receptor: implications for rheumatic diseases. Clin. Exp. Rheumatol. 29 (suppl. 68), S32-S41 (2011).
20. T. Kino, G. P. Chrousos, Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases. Endocr. Dev. 20, 116-126 (2011).
21. M. Doi, J. Hirayama, P. Sassone-Corsi, Circadian regulator CLOCK is a histone acetyltransferase. Cell 125, 497-508 (2006).
22. H. Chen, R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, R. M. Evans, Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569-580 (1997).
23. N. Nader, G. P. Chrousos, T. Kino, Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: Potential physiological implications. FASEB J. 23, 1572-1583 (2009).
24. P. McNamara, S. B. Seo, R. D. Rudic, A. Sehgal, D. Chakravarti, G. A. FitzGerald, Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105, 877-889 (2001).
25. E. Charmandari, G. P. Chrousos, G. I. Lambrou, A. Pavlaki, H. Koide, S. S. Ng, T. Kino, Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS ONE 6, e25612 (2011).
26. I. Schmutz, J. A. Ripperger, S. Baeriswyl-Aebischer, U. Albrecht, The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev. 24, 345-357 (2010).
27. K. A. Lamia, S. J. Papp, R. T. Yu, G. D. Barish, N. H. Uhlenhaut, J. W. Jonker, M. Downes, R. M. Evans, Cryptochromes mediate rhythmic repression of the glucocorticoid receptor. Nature 480, 552-556 (2011).
28. A. Balsalobre, S. A. Brown, L. Marcacci, F. Tronche, C. Kellendonk, H. M. Reichardt, G. Schütz, U. Schibler, Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289, 2344-2347 (2000).
29. A. Ishida, T. Mutoh, T. Ueyama, H. Bando, S. Masubuchi, D. Nakahara, G. Tsujimoto, H. Okamura, Light activates the adrenal gland: Timing of gene expression and glucocorticoid release. Cell Metab. 2, 297-307 (2005).
30. H. Oster, S. Damerow, S. Kiessling, V. Jakubcakova, D. Abraham, J. Tian, M. W. Hoffmann, G. Eichele, The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 4, 163-173 (2006).
31. G. H. Son, S. Chung, H. K. Choe, H. D. Kim, S. M. Baik, H. Lee, H. W. Lee, S. Choi, W. Sun, H. Kim, S. Cho, K. H. Lee, K. Kim, Adrenal peripheral clock controls the autonomous circadian rhythm of glucocorticoid by causing rhythmic steroid production. Proc. Natl. Acad. Sci. U.S.A. 105, 20970-20975 (2008).
32. P. W. Gold, G. P. Chrousos, Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7, 254-275 (2002).
33. F. A. Scheer, M. F. Hilton, C. S. Mantzoros, S. A. Shea, Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A. 106, 4453-4458 (2009).
34. S. L. Lightman, C. C. Wiles, H. C. Atkinson, D. E. Henley, G. M. Russell, J. A. Leendertz, M. A. McKenna, F. Spiga, S. A. Wood, B. L. Conway-Campbell, The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 583, 255-262 (2008).